UPL Ltd
UPL Ltd
Chemicals F&OKey Fundamentals
MidcapPesticides & AgrochemicalsChemicalsInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view UPL Ltd insights
47 extracted metrics + investor summaries across FY15–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
1- Company has been maintaining a healthy dividend payout of 24.4%
Weaknesses
3- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 6.02% over past five years.
- Company has a low return on equity of 1.87% over last 3 years.
Growth Rate
AI Analysis — Bull vs Bear
UPL Ltd is an agrochemical company with a market cap of ₹47,746 Cr trading at a PE of 20.6x. After a difficult multi-year period of declining profits (compounded profit CAGR of -21% over 3 years), the company is showing signs of recovery with TTM sales growth of 13% and profit growth of 36%. In FY25, UPL reported 8% revenue growth, 47% EBITDA growth, and 175% growth in net profits while reducing net debt by ₹83.2 Bn to ₹138.6 Bn.
- Strong TTM revenue growth of 13% signals recovery after 3-year compounded sales CAGR of -1%
- TTM profit growth of 36% shows sharp earnings recovery after years of decline
- FY25 EBITDA grew 47% YoY, reaching the upper end of management guidance
- Net debt reduced by ₹83.2 Bn (approximately $1.04 Bn) in FY25 to ₹138.6 Bn, driven by strong operating free cash flow of ₹44.5 Bn
- 10-year compounded sales CAGR of 14% demonstrates long-term revenue scaling ability in global agrochemicals
- PE of 20.6x is reasonable for a cyclical recovery story given 175% net profit growth in FY25
- Consistent dividend payout of 24.4% with current yield of 1.06% provides some shareholder return
- Q2 FY25 volumes grew 16% YoY indicating underlying demand recovery across geographies
- 3-year ROE average of just 1.87% indicates very poor capital efficiency and value destruction for shareholders
- Low interest coverage ratio suggests debt servicing remains a significant burden on earnings
- 5-year compounded profit CAGR of -10% shows prolonged earnings destruction despite global presence
- Stock has delivered -17% return over 1 year and -5% CAGR over 5 years, significantly underperforming broader markets
- 5-year compounded sales growth of only 6% is poor for a company that made large debt-funded acquisitions
- Price-to-book of 1.38x with last year ROE of just 6% implies the company barely earns its cost of equity
- Net debt of ₹138.6 Bn even after significant reduction remains elevated relative to ₹47,746 Cr market cap
- 10-year compounded profit CAGR of only 6% versus 14% sales CAGR indicates persistent margin compression over the long term
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- CEO Mike Frank stepping down Aug 3
CEO Mike Frank resigns effective August 31, 2026 after 4.5 years due to personal commitments, creating leadership uncertainty at the top.
- Q1FY26 net loss persists Aug 4
UPL posted a consolidated net loss of ₹73 crore in Q1FY26. While narrower than ₹176 crore loss YoY, the company remains unprofitable.
- Advanta acquires Egyptian seed firm Aug 14
UPL subsidiary Advanta Holdings acquiring Misr Hytech Seed International for ~US$110 million, targeting leadership in Middle East and Africa seed market with closing by Jan 31, 2027.
- Revenue grows 10.5% YoY in Q1 Aug 4
Consolidated revenue rose 10.5% YoY to ₹10,181 crore in Q1FY26, and net loss narrowed significantly from ₹176 crore to ₹73 crore.
- Exchanges clear Composite Scheme Jul 29
BSE issued 'no adverse observations' and NSE gave 'No Objection' on July 29 for UPL's Composite Scheme of Arrangement involving four entities.
- AGM approves ₹6 dividend Aug 6
Shareholders approved ₹6 per share dividend and re-elected Jaidev Shroff as director at the AGM held August 6, 2026.
- Acquires US water treatment firm Jul 28
UPL NA Inc acquired 100% of Sustainable Tech Inc, USA for US$1 on July 27, expanding presence in aquatics and water treatment sector.
- Demuric acquires 21.41% UPL stake Jul 22
Demuric Holdings acquired 21.41% in UPL via amalgamation scheme on July 21, 2026, raising total holding to 22.03%.
- Bioplanta stake divested for $20 Jul 29
UPL Brasil sold entire stake in negative net worth JV Bioplanta Nutricao Vegetal for USD 20, closing by July 31, 2026.
- Q1 FY27 earnings call scheduled Jul 27
Board meeting and Q1 FY27 earnings call scheduled for August 3, 2026 at 16:30 IST to discuss June quarter results.
TL;DR: UPL is showing revenue recovery with 10.5% YoY growth and narrowing losses, while actively pursuing inorganic growth through the $110M Egyptian seed acquisition and US water treatment deal. Key risks include continued net losses and CEO departure creating near-term leadership transition uncertainty. The Composite Scheme clearance and promoter consolidation via Demuric suggest structural changes ahead. The trend is gradually improving on the top line, but profitability remains the key watchpoint for coming quarters.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8,963 | 10,170 | 9,887 | 14,078 | 9,067 | 11,090 | 10,907 | 15,573 | 9,216 | 12,019 | 12,269 | 18,335 | 10,181 |
| Expenses | 7,747 | 9,049 | 9,820 | 12,230 | 7,998 | 9,873 | 9,229 | 12,409 | 7,820 | 10,072 | 10,033 | 14,854 | 8,814 |
| Operating Profit | 1,216 | 1,121 | 67 | 1,848 | 1,069 | 1,217 | 1,678 | 3,164 | 1,396 | 1,947 | 2,236 | 3,481 | 1,367 |
| OPM % | 14% | 11% | 0.7% | 13% | 12% | 11% | 15% | 20% | 15% | 16% | 18% | 19% | 13% |
| Other Income | 58 | 18 | 134 | 66 | 49 | 103 | 94 | -168 | 152 | 392 | 36 | 162 | 208 |
| Interest | 700 | 871 | 1,191 | 1,090 | 913 | 1,070 | 730 | 914 | 1,007 | 784 | 774 | 836 | 852 |
| Depreciation | 636 | 657 | 676 | 794 | 660 | 697 | 688 | 705 | 731 | 771 | 827 | 915 | 832 |
| PBT | -62 | -389 | -1,666 | 30 | -455 | -447 | 354 | 1,377 | -190 | 784 | 671 | 1,892 | -109 |
| Tax % | -265% | -25% | -4% | 367% | 16% | 31% | -141% | 22% | -7% | 22% | 27% | 32% | -33% |
| Net Profit | 102 | -293 | -1,607 | -80 | -527 | -585 | 853 | 1,079 | -176 | 612 | 490 | 1,294 | -73 |
| EPS in Rs | 1.97 | -2.24 | -14.41 | 0.47 | -4.55 | -5.25 | 9.81 | 10.61 | -1.04 | 6.56 | 4.7 | 12.57 | 0.12 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12,091 | 14,048 | 16,312 | 17,378 | 21,837 | 35,756 | 38,694 | 46,240 | 53,576 | 43,098 | 46,637 | 51,839 | 52,804 |
| Expenses | 9,728 | 11,700 | 13,346 | 13,966 | 18,024 | 28,984 | 30,342 | 36,711 | 43,380 | 38,801 | 39,509 | 42,761 | 43,773 |
| Operating Profit | 2,363 | 2,348 | 2,966 | 3,412 | 3,813 | 6,772 | 8,352 | 9,529 | 10,196 | 4,297 | 7,128 | 9,078 | 9,031 |
| OPM % | 20% | 17% | 18% | 20% | 17% | 19% | 22% | 21% | 19% | 10% | 15% | 18% | 17% |
| Other Income | -11 | 149 | 363 | 351 | -197 | -515 | 62 | 91 | 464 | 231 | 78 | 724 | 798 |
| Interest | 517 | 704 | 735 | 783 | 963 | 1,481 | 2,060 | 2,295 | 2,963 | 3,852 | 3,627 | 3,401 | 3,246 |
| Depreciation | 425 | 676 | 672 | 675 | 880 | 2,012 | 2,173 | 2,359 | 2,547 | 2,763 | 2,750 | 3,244 | 3,345 |
| PBT | 1,410 | 1,117 | 1,922 | 2,305 | 1,773 | 2,764 | 4,181 | 4,966 | 5,150 | -2,087 | 829 | 3,157 | 3,238 |
| Tax % | 17% | 15% | 10% | 12% | 11% | 21% | 16% | 11% | 14% | -10% | 1% | 30% | — |
| Net Profit | 1,187 | 952 | 1,733 | 2,030 | 1,575 | 2,178 | 3,495 | 4,437 | 4,414 | -1,878 | 820 | 2,220 | 2,323 |
| EPS in Rs | 15.82 | 13 | 20.18 | 23.57 | 17.35 | 20.66 | 33.4 | 42.18 | 42.28 | -14.21 | 10.62 | 22.78 | 23.95 |
| Div. Payout % | 19% | 23% | 20% | 20% | 27% | 26% | 27% | 21% | 21% | -6% | 53% | 26% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 86 | 86 | 101 | 102 | 102 | 153 | 153 | 153 | 150 | 150 | 159 | 169 |
| Reserves | 5,775 | 5,803 | 7,214 | 9,067 | 14,613 | 19,129 | 20,734 | 24,508 | 26,708 | 24,657 | 29,054 | 34,527 |
| Borrowings | 3,281 | 5,258 | 6,443 | 6,638 | 29,139 | 29,388 | 24,519 | 26,746 | 23,939 | 29,754 | 25,099 | 23,576 |
| Other Liabilities | 5,143 | 5,722 | 6,454 | 7,148 | 18,581 | 19,758 | 23,359 | 29,196 | 35,318 | 30,579 | 31,700 | 34,847 |
| Total Liabilities | 14,284 | 16,869 | 20,212 | 22,955 | 62,435 | 68,428 | 68,765 | 80,603 | 86,115 | 85,140 | 86,012 | 93,119 |
| Fixed Assets | 4,031 | 3,862 | 4,071 | 4,437 | 32,149 | 35,321 | 34,765 | 36,193 | 38,713 | 39,056 | 39,084 | 42,153 |
| CWIP | 583 | 484 | 792 | 1,319 | 1,855 | 2,073 | 2,117 | 2,501 | 2,818 | 2,965 | 2,546 | 3,147 |
| Investments | 764 | 335 | 378 | 1,034 | 708 | 558 | 618 | 1,922 | 1,615 | 2,154 | 2,328 | 2,666 |
| Other Assets | 8,906 | 12,188 | 14,971 | 16,165 | 27,723 | 30,476 | 31,265 | 39,987 | 42,969 | 40,965 | 42,054 | 45,153 |
| Total Assets | 14,284 | 16,869 | 20,212 | 22,955 | 62,435 | 68,428 | 68,765 | 80,603 | 86,115 | 85,140 | 86,012 | 93,119 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 1,409 | 1,396 | 2,585 | 2,839 | 2,356 | 8,739 | 7,212 | 6,496 | 7,751 | 2,321 | 10,151 | 7,855 |
| Investing | -463 | -1,734 | -1,022 | -2,059 | -31,282 | -2,666 | -2,426 | -3,575 | -1,354 | -2,509 | -1,823 | -1,475 |
| Financing | -991 | 469 | 140 | -801 | 28,893 | -2,175 | -6,713 | -1,921 | -6,227 | 164 | -4,793 | -9,883 |
| Net Cash Flow | -45 | 131 | 1,703 | -21 | -33 | 3,898 | -1,927 | 1,000 | 170 | -24 | 3,535 | -3,503 |
| Free Cash Flow | 878 | 703 | 1,382 | 1,435 | 803 | 6,804 | 5,147 | 3,931 | 5,462 | 367 | 8,896 | 5,502 |
| CFO/OP | 71 | 78 | 99 | 90 | 71 | 141 | 95 | 79 | 88 | 81 | 156 | 93 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 115 | 133 | 127 | 127 | 195 | 121 | 115 | 121 | 124 | 138 | 121 | 126 |
| Inventory Days | 178 | 204 | 194 | 204 | 306 | 153 | 180 | 216 | 187 | 198 | 155 | 179 |
| Days Payable | 195 | 213 | 228 | 255 | 330 | 199 | 244 | 274 | 236 | 196 | 164 | 169 |
| Cash Conversion Cycle | 98 | 124 | 93 | 76 | 171 | 75 | 51 | 64 | 76 | 141 | 113 | 135 |
| Working Capital Days | 45 | 48 | 84 | 94 | 127 | 59 | 52 | 36 | 46 | 52 | 9 | 5 |
| ROCE % | 21% | 19% | 22% | 21% | 10% | 10% | 13% | 14% | 14% | 3% | 8% | 10% |
Documents
Frequently Asked Questions about UPL Ltd
What does UPL Ltd do?
Where is UPL Ltd (UPL) listed?
Which sector does UPL Ltd belong to?
What is the market capitalisation of UPL Ltd?
What is the PE ratio of UPL Ltd?
What is the 52-week high and low of UPL Ltd?
Does UPL Ltd pay dividends?
What is the Return on Equity (ROE) of UPL Ltd?
How can I research UPL Ltd on Tapetide?
Company Information
UPL is principally engaged in the business of agrochemicals, industrial chemicals, chemical intermediates, speciality chemicals and production and sale of field crops and vegetable seeds.